Abstract | AIMS: METHODS: We evaluated 85 children, aged 9-16 years, with type 1 diabetes, divided into four groups: controls (n=23), experienced carbC (n=19), experienced carbC+ABC (n=18) and non-experienced carbC+ABC (n=25). Glycated haemoglobin (HbA1c), insulin use, and glycaemic variability - evaluated as high blood glucose index (HBGI) and low blood glucose index (LBGI) - were assessed at baseline and after 6 and 18 months. RESULTS: At baseline, age, disease duration, BMI, HbA1c, insulin use, and HBGI (but not LBGI; p=0.020) were similar for all groups. After 6 months, HbA1c improved from baseline, although not significantly - patients using ABC (according to manufacturer's recommendations) HbA1c 7.14 ± 0.41% at 6 months vs. 7.35 ± 0.53% at baseline, (p=0.136) or without carbC experience HbA1c 7.61±0.62% vs. 7.95 ± 0.99% (p=0.063). Patients using ABC had a better HBGI (p=0.001) and a slightly worse LBGI (p=0.010) than those not using ABC. ABC settings were then personalised. At 18 months, further improvements in HbA1c were seen in children using the ABC, especially in the non-experienced carbC group (-0.42% from baseline; p=0.018). CONCLUSIONS: CarbC helped to improve glycaemic control in children with type 1 diabetes using multiple daily injections. ABC use led to greater improvements in HbA1c, HBGI and LBGI compared with patients using only carbC, regardless of experience with carbC.
|
Authors | Ivana Rabbone, Andrea E Scaramuzza, Maria Giovanna Ignaccolo, Davide Tinti, Sabrina Sicignano, Francesca Redaelli, Laura De Angelis, Alessandra Bosetti, Gian Vincenzo Zuccotti, Franco Cerutti |
Journal | Diabetes research and clinical practice
(Diabetes Res Clin Pract)
Vol. 103
Issue 3
Pg. 388-94
(Mar 2014)
ISSN: 1872-8227 [Electronic] Ireland |
PMID | 24447811
(Publication Type: Comparative Study, Journal Article, Observational Study)
|
Copyright | Copyright © 2013 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Blood Glucose
- Dietary Carbohydrates
- Glycated Hemoglobin A
- Insulin
- hemoglobin A1c protein, human
|
Topics |
- Adolescent
- Blood Glucose
(metabolism)
- Case-Control Studies
- Child
- Diabetes Mellitus, Type 1
(blood, drug therapy)
- Dietary Carbohydrates
(administration & dosage, analysis)
- Female
- Follow-Up Studies
- Glycated Hemoglobin
(analysis)
- Glycemic Index
- Humans
- Hyperglycemia
(drug therapy)
- Hypoglycemia
(drug therapy)
- Insulin
(administration & dosage)
- Insulin Infusion Systems
- Male
- Prospective Studies
|